We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+13.25%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$915M
AUM Growth
-$18.6M
(-2%)
Cap. Flow
-$44.1M
Cap. Flow
% of AUM
-4.82%
Top 10 Holdings %
Top 10 Hldgs %
78.79%
Holding
44
New
14
Increased
4
Reduced
5
Closed
14
Top Buys
| 1 |
Scholar Rock
SRRK
|
+$50.1M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
+$35M |
| 3 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$25.1M |
| 4 |
UBX
Unity Biotechnology
UBX
|
+$24.6M |
| 5 |
KZR
Kezar Life Sciences
KZR
|
+$22.2M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
+$49.8M |
| 2 |
Wave Life Sciences
WVE
|
+$45M |
| 3 |
Ascendis Pharma A/S
ASND
|
+$23.6M |
| 4 |
APLS
Apellis Pharmaceuticals
APLS
|
+$23.4M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$22.7M |
Sector Composition
| 1 | Healthcare | 93.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
1
Kyntra Bio
KYNB
$29.5M
| $126M | 13.81% |
80,690
+593
| +0.7% | +$773K |
|
2
Ironwood Pharmaceuticals
IRWD
$667M
| $120M | 13.06% |
7,462,587
+435,201
| +6% | +$6.44M |
|
3
Assembly Biosciences
ASMB
$529M
| $115M | 12.62% |
245,264
| – | – |
|
|
4
Ascendis Pharma A/S
ASND
$17.4B
| $97.4M | 10.65% |
1,464,067
-358,508
| -20% | -$23.6M |
|
5
Kura Oncology
KURA
$1,000M
| $71.1M | 7.77% |
3,904,675
+137,823
| +4% | +$2.33M |
|
|
6
Madrigal Pharmaceuticals
MDGL
$12.6B
| $55.8M | 6.1% |
+199,500
| New | +$35M |
|
|
7
Scholar Rock
SRRK
$6.46B
| $41.7M | 4.56% |
+2,671,161
| New | +$50.1M |
|
|
DRNA
8
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $36.3M | 3.97% |
2,961,147
-1,803,300
| -38% | -$22.7M |
|
9
MacroGenics
MGNX
$270M
| $30M | 3.27% |
1,450,606
| – | – |
|
10
Arcus Biosciences
RCUS
$3.51B
| $27.4M | 2.99% |
2,236,387
| – | – |
|
|
UBX
11
DELISTED
Unity Biotechnology
UBX
| $25.3M | 2.77% |
+168,064
| New | +$24.6M |
|
|
KZR
12
DELISTED
Kezar Life Sciences
KZR
| $22M | 2.41% |
+127,220
| New | +$22.2M |
|
|
SGMO
13
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $21.4M | 2.34% |
+1,509,671
| New | +$25.1M |
|
14
Dianthus Therapeutics
DNTH
$5.5B
| $20.8M | 2.27% |
+96,131
| New | +$21.7M |
|
|
IMDZ
15
DELISTED
Immune Design Corp.
IMDZ
| $20.2M | 2.21% |
4,437,600
| – | – |
|
|
16
Wave Life Sciences
WVE
$1.14B
| $15.8M | 1.73% |
412,871
-1,046,201
| -72% | -$45M |
|
|
SURF
17
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $14.5M | 1.59% |
+890,808
| New | +$12.9M |
|
|
EIGR
18
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $12.7M | 1.39% |
+34,650
| New | +$12.3M |
|
|
ACHN
19
DELISTED
Achillion Pharmaceuticals
ACHN
| $11M | 1.2% |
3,887,407
+219,100
| +6% | +$746K |
|
|
KDMN
20
DELISTED
Kadmon Holdings, Inc.
KDMN
| $9.97M | 1.09% |
+2,500,000
| New | +$9.76M |
|
|
DBVT
21
DBV Technologies
DBVT
$927M
| $5.75M | 0.63% |
29,810
-15,190
| -34% | -$3.42M |
|
22
Corvus Pharmaceuticals
CRVS
$1.26B
| $4.95M | 0.54% |
450,400
-19,300
| -4% | -$215K |
|
23
Neurogene
NGNE
$783M
| $3.05M | 0.33% |
+57,500
| New | +$15M |
|
24
Traws Pharma
TRAW
$10.7M
| $3.03M | 0.33% |
+1,333
| New | +$3.87M |
|
|
PHXM
25
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
| $1.73M | 0.19% |
+15,396
| New | +$2.89M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM